Parliamentary.ai


by Munro Research

Reporting of Injuries, Diseases and Dangerous Occurrences Regulation Bill


Official Summary

A Bill to reduce the duties on employers to report matters under the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 1995.

Summary powered by AnyModel

Overview

This bill, the Reporting of Injuries, Diseases and Dangerous Occurrences Regulation Act 2011, aims to simplify the reporting requirements for employers under the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 1995. It does this by repealing a specific regulation, reducing the administrative burden on businesses.

Description

The bill repeals Regulation 3(2) of the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 1995. This regulation outlines specific reporting requirements for employers. The repeal simplifies these requirements. The Secretary of State is given the power to create further regulations to manage the transition, ensuring a smooth changeover. These subsequent regulations will require parliamentary approval. The Act applies to England, Wales and Scotland and will come into force two months after its passage.

Government Spending

The bill is expected to reduce government spending by lessening the administrative burden on enforcing the regulations. However, precise cost savings are not specified in the provided text.

Groups Affected

The primary group affected is employers. The bill reduces their reporting responsibilities, potentially saving them time and resources. The impact on health and safety regulators and enforcement bodies may be indirect, with a potential for reduced reporting of incidents.

Full Text

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.